Professional
Added to YB: 2024-12-16
Pitch date: 2024-12-13
TELO [bearish]
Telomir Pharmaceuticals, Inc.
+71.57%
current return
Author Info
White Diamond Research is a small cap research firm (often short). Sign up for the newsletter.
Company Info
Telomir Pharmaceuticals, Inc., a preclinical stage pharmaceutical company, is engaged in the advancement of age reversal science.
Market Cap
$154.0M
Pitch Price
$5.10
Price Target
1.00 (-31%)
Dividend
N/A
EV/EBITDA
N/A
P/E
-6.54
EV/Sales
N/A
Sector
Pharmaceuticals
Category
value
Telomir Pharmaceuticals Is A Biotech Pump And Dump Scheme Remaining In the Preclinical Stage
TELO short: Pre-clinical biotech with questionable founder history, overvalued vs peers at $200M cap. No mammal study results reported, only fish/worm data. Insiders up 3000% pre-IPO. Cash low, dilution likely. Excessive private jet spending. Expect sub-$1 price, no IND filing in 2025.
Read full article (12 min)